XenoPort Inc (XNPT)

7.07
0.05 0.71
Prev Close 7.02
Open 7.04
Day Low/High 7.02 / 7.07
52 Wk Low/High 3.35 / 7.86
Volume 2.62M
Avg Volume 1.64M
Exchange
Shares Outstanding 63.53M
Market Cap 449.13M
EPS -1.30
Div & Yield N.A. (N.A)
XenoPort To Release First Quarter Financial Results On May 6, 2015

XenoPort To Release First Quarter Financial Results On May 6, 2015

XenoPort, Inc. (Nasdaq: XNPT) announced today that it will release its first quarter financial results on May 6, 2015 at approximately 4:30 p.

XenoPort To Present New Data Analyses For HORIZANT (gabapentin Enacarbil) At The 67th Annual Meeting Of The American Academy Of Neurology

XenoPort To Present New Data Analyses For HORIZANT (gabapentin Enacarbil) At The 67th Annual Meeting Of The American Academy Of Neurology

XenoPort, Inc. (Nasdaq:XNPT) announced today that it will present pooled post-hoc analyses for gabapentin enacarbil, the active ingredient in HORIZANT ® (gabapentin enacarbil) Extended-Release Tablets, at the upcoming...

First Week of May 15th Options Trading For XenoPort (XNPT)

First Week of May 15th Options Trading For XenoPort (XNPT)

Investors in XenoPort Inc saw new options begin trading this week, for the May 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the XNPT options chain for the new May 15th contracts and identified the following call contract of particular interest.

XenoPort To Present At The Cowen And Company 35th Annual Health Care Conference

XenoPort To Present At The Cowen And Company 35th Annual Health Care Conference

XenoPort, Inc. (NASDAQ: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the Cowen and Company 35th Annual Health Care Conference.

XenoPort Reports Fourth Quarter And Year-End 2014 Financial Results

XenoPort Reports Fourth Quarter And Year-End 2014 Financial Results

XenoPort, Inc. (Nasdaq:XNPT) announced today its financial results for the fourth quarter and year ended December 31, 2014.

XenoPort To Present At The RBC Capital Markets' Global Healthcare Conference

XenoPort To Present At The RBC Capital Markets' Global Healthcare Conference

XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the RBC Capital Markets' Global Healthcare Conference.

Commit To Purchase XenoPort At $6, Earn 22.7% Annualized Using Options

Commit To Purchase XenoPort At $6, Earn 22.7% Annualized Using Options

Investors eyeing a purchase of XenoPort Inc stock, but cautious about paying the going market price of $7.21/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the June put at the $6 strike, which has a bid at the time of this writing of 50 cents.

XenoPort To Release Fourth Quarter And Year-End Financial Results On February 19, 2015

XenoPort To Release Fourth Quarter And Year-End Financial Results On February 19, 2015

XenoPort, Inc. (Nasdaq:XNPT) announced today that it will release its fourth quarter and year-end financial results on February 19, 2015 at approximately 4:30 p.

XenoPort Announces Pricing Of $100 Million 2.50% Convertible Senior Notes Due 2022

XenoPort Announces Pricing Of $100 Million 2.50% Convertible Senior Notes Due 2022

XenoPort, Inc. (NASDAQ: XNPT) announced today the pricing of $100 million aggregate principal amount of 2.

XenoPort Announces Proposed Offering Of $100 Million Convertible Senior Notes Due 2022

XenoPort Announces Proposed Offering Of $100 Million Convertible Senior Notes Due 2022

XenoPort, Inc. (Nasdaq: XNPT) announced today that it intends to offer, subject to market and other conditions, $100 million aggregate principal amount of convertible senior notes due 2022 in a private placement to...

XenoPort Provides Highlights Of HORIZANT Prescription Trends And Update On Development For Alcohol Use Disorder

XenoPort Provides Highlights Of HORIZANT Prescription Trends And Update On Development For Alcohol Use Disorder

XenoPort (NASDAQ:XNPT) today reported an update on prescription trends and further development of HORIZANT ® (gabapentin enacarbil) Extended-Release Tablets, including feedback from the U.

Uncharted Waters

This is an odd market right now.

Action Was Ugly, But Healthy

If the market gaps down in the morning, watch for the dip buyers.

Random, Machine-Driven Trading

Some positives, but plenty of land mines as well.

Stocks Fall in Light Trading as Oil and Greece Weigh on Markets

Stocks Fall in Light Trading as Oil and Greece Weigh on Markets

Oil and Greece were the focus of 2014's penultimate trading session in what was an otherwise quiet day.

Running Down the Clock

Expect more of the same market action tomorrow.

S&P 500 Moves Off Session Lows as Crude Prices Stabilize

S&P 500 Moves Off Session Lows as Crude Prices Stabilize

The S&P 500 fell from record highs as global oversupply of oil and political uncertainty in Greece caused headaches in an otherwise quiet week.

Dow Down For Second Straight Day as Oil Worries Loom Large

Dow Down For Second Straight Day as Oil Worries Loom Large

Traders continue to fret over oil prices and Greece's political uncertainty on Tuesday in a quiet week with little else to divert attention.

Stock Futures Slip as Oil Price Pressure Weighs on Sentiment

Stock Futures Slip as Oil Price Pressure Weighs on Sentiment

Traders continue to fret over oil prices and Greece's political uncertainty on Tuesday in a quiet week with little else to divert attention.

'Fast Money' Recap: Is Billionaire David Tepper Right About the Stock Market?

'Fast Money' Recap: Is Billionaire David Tepper Right About the Stock Market?

The trading panel discussed the S&P 500, cyber security stocks and whether Gilead Sciences is buying back its stock.

XenoPort To Present At The Credit Suisse Healthcare Conference

XenoPort To Present At The Credit Suisse Healthcare Conference

XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 2014 Credit Suisse Healthcare Conference in Phoenix, Arizona.

XenoPort Reports Third Quarter Financial Results

XenoPort Reports Third Quarter Financial Results

XenoPort, Inc. (Nasdaq: XNPT) announced today financial results for the third quarter and nine months ended September 30, 2014.

First Week of June 2015 Options Trading For XenoPort (XNPT)

First Week of June 2015 Options Trading For XenoPort (XNPT)

Investors in XenoPort Inc saw new options become available this week, for the June 2015 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 227 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

XenoPort To Release Third Quarter Financial Results On November 4

XenoPort To Release Third Quarter Financial Results On November 4

XenoPort, Inc. (Nasdaq:XNPT) announced today that it will release its third quarter financial results on November 4, 2014 at approximately 4:30 p.

XenoPort To Present Data For Novel Fumarate Analog XP23829 At The 2014 Joint ACTRIMS-ECTRIMS Meeting In Boston

XenoPort To Present Data For Novel Fumarate Analog XP23829 At The 2014 Joint ACTRIMS-ECTRIMS Meeting In Boston

XenoPort, Inc. (Nasdaq:XNPT) announced today that it will present data on XP23829, an investigational prodrug of monomethyl fumarate (MMF), at the 2014 Joint ACTRIMS-ECTRIMS Meeting in Boston.

XenoPort And The NIAAA Announce Clinical Trial Agreement To Study HORIZANT As A Potential Treatment For Alcohol Use Disorder

XenoPort And The NIAAA Announce Clinical Trial Agreement To Study HORIZANT As A Potential Treatment For Alcohol Use Disorder

XenoPort, Inc. (Nasdaq:XNPT) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) announced today that they have entered into an agreement to conduct a clinical trial of HORIZANT ® (gabapentin...

XNPT: Insiders vs. Shorts

XNPT: Insiders vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 07/31/2014 settlement date, and XenoPort Inc is one of the most shorted stocks of the Russell 3000, based on 26.25 "days to cover" versus the median component at 6.30. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

XenoPort Reports Second Quarter Financial Results

XenoPort Reports Second Quarter Financial Results

XenoPort, Inc. (Nasdaq: XNPT) announced today financial results for the second quarter and six months ended June 30, 2014.

XenoPort To Release Second Quarter Financial Results On August 6, 2014

XenoPort To Release Second Quarter Financial Results On August 6, 2014

XenoPort, Inc. (Nasdaq:XNPT) announced today that it will release its second quarter financial results on August 6, 2014 at approximately 4:30 p.

XenoPort Announces Initiation Of A Phase 2 Clinical Trial Of XP23829 In Patients With Psoriasis

XenoPort Announces Initiation Of A Phase 2 Clinical Trial Of XP23829 In Patients With Psoriasis

XenoPort, Inc. (Nasdaq: XNPT) announced today that it has initiated a Phase 2 clinical trial of XP23829, its proprietary investigational next-generation fumaric acid product candidate.